More than 400 million people experience a urinary tract infection every year, and some epidemiological studies estimate that more than half of all women will develop at least one in their lifetime. Most UTIs are caused by pathogenic strains of Escherichia coli bacteria, and the antibiotic fosfomycin is often prescribed as the first line of treatment. However, increasing resistance to antibiotics is driving a search for alternative approaches to treatment.
This article was originally published on MedicalXpress.com
